Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome

NCT03530293 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

81

Enrollment

INDUSTRY

Sponsor class

Stopped Futility

Conditions

Tourette Syndrome

Interventions

DRUG: Valbenazine
DRUG: Placebo oral capsule

Sponsor

Neurocrine Biosciences